Title:
AGENT FOR TREATMENT AND/OR PREVENTION OF INFLAMMATORY EYE DISORDER
Document Type and Number:
WIPO Patent Application WO/2018/056268
Kind Code:
A1
Abstract:
Provided is an agent for the treatment and/or prevention of inflammatory eye disorder, containing (3S, 4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxylic acid amide or a salt thereof.
Inventors:
YOSHIDA ATSUSHI (JP)
FUJISAWA TOYOMI (JP)
FUJISAWA TOYOMI (JP)
Application Number:
PCT/JP2017/033760
Publication Date:
March 29, 2018
Filing Date:
September 19, 2017
Export Citation:
Assignee:
SANTEN PHARMACEUTICAL CO LTD (JP)
International Classes:
A61K31/4985; A61P1/04; A61P17/06; A61P19/02; A61P27/02; A61P27/04; A61P27/06; A61P27/12; A61P27/14; A61P29/00; A61P37/08
Domestic Patent References:
| WO2016033308A1 | 2016-03-03 |
Foreign References:
| US20150118229A1 | 2015-04-30 | |||
| JP2012504639A | 2012-02-23 |
Attorney, Agent or Firm:
TSUKUNI & ASSOCIATES et al. (JP)
Download PDF: